Joost Van Den Berg PharmD, PhD

Joost van den Berg was trained as a pharmacist and developed a special interest in immunotherapy during his PhD at the Netherlands Cancer Institute (NKI)/ Utrecht University and subsequent postdoctoral training at the Center for Cancer Immune Therapy (CCIT) in Copenhagen, Denmark. Currently, he is responsible for the development and production of immunotherapeutic products in the in-house GMP facility of the NKI. In addition, he is involved in the execution of immunotherapy trials, including DNA vaccine trial, and adoptive cell therapy trials with gene modified peripheral blood T cells and Tumor-Infiltrating Lymphocytes.